R. Izu

Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: an epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma

Yeray Peñate, B. Hernández‐Machín, Lina Pérez‐Méndez et al. · British Journal of Dermatology · 2012 · 73 citations

Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma

Naiara Nieto-Rementería, Gorka Pérez‐Yarza, María Dolores Boyano et al. · British Journal of Dermatology · 2008 · 59 citations

First-line treatment in lymphomatoid papulosis: a retrospective multicentre study

Ricardo Fernández‐de‐Misa, B. Hernández‐Machín, Octavio Servitje et al. · Clinical and Experimental Dermatology · 2017 · 40 citations · Full text

Vitronectin and dermcidin serum levels predict the metastatic progression of <scp>AJCC I–II</scp> early‐stage melanoma

Idoia Ortega‐Martínez, Jesús Gardeazábal, Asier Erramuzpe et al. · International Journal of Cancer · 2016 · 39 citations · Full text

Serum markers improve current prediction of metastasis development in early‐stage melanoma patients: a machine learning‐based study

Filippo Mancuso, Sergio Lage, Javier Rasero et al. · Molecular Oncology · 2020 · 28 citations · Full text